FDA Warning Letter — BP

Case 670180 — FEI 3029552852

The FDA took a Warning Letter action against BP on Oct 24, 2023 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Oct 24, 2023
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.